This inventor holds 2 USPTO granted patents. Top assignee: Alnylam Pharmaceuticals, Inc.. Active years: 2015-2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015-2018
Title: The Innovative Contributions of Marija Prhavc
Introduction
Marija Prhavc, an esteemed inventor based in Cambridge, MA, has made significant strides in the field of molecular biology. With a focus on nucleoside and oligonucleotide research, she holds two patents that reflect her innovative approach to gene expression regulation.
Latest Patents
Marija's latest patents revolve around the development of 5' phosphate mimics. These patents provide detailed methodologies involving nucleosides and oligonucleotides characterized by specific formulations (IVc and Vc). One innovative aspect of her invention includes modified nucleosides that aim to inhibit gene expression within cells. The method outlined in her patents involves contacting an oligonucleotide with a cell and maintaining the conditions necessary to promote degradation of the target mRNA, showcasing her contributions to gene therapy and molecular research.
Career Highlights
Marija Prhavc currently works at Alnylam Pharmaceuticals, Inc., a company renowned for its cutting-edge research in RNA interference and other genetic therapies. Her role at Alnylam has positioned her at the forefront of pharmaceutical innovations, where her research contributes to developing transformative treatments.
Collaborations
Throughout her career, Marija has collaborated with notable scientists such as Muthiah Manoharan and Kallanthottathil G Rajeev. These collaborations have fostered a productive environment that promotes innovative thinking and accelerates the advancement of vital biotechnological solutions.
Conclusion
Marija Prhavc's influential work and her two patents reflect her dedication and significant contribution to the field of molecular biology. As an inventor, her research continues to pave the way for advancements in gene expression technologies, making her a prominent figure in the scientific community. Her ongoing collaboration with esteemed colleagues further amplifies her impact, ensuring that she remains a key player in the evolution of pharmaceutical innovations.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile